LC-MS/MS Method for Therapeutic Drug Monitoring of Polymyxin B in Human Plasma
WANG Yu,HUANG Xiaolan,ZHANG Chuhan,QU Xingyi,GUO Chenxue,CHEN Yan,FAN Yaxin,GUO Beining,ZHANG Jing,LIU Xiaofen
DOI: https://doi.org/10.16718/j.1009-7708.2022.06.007
2022-01-01
Abstract:Objective To establish a liquid chromatography-tandem mass spectrometry （LC-MS/MS） method for therapeutic drug monitoring of polymyxin B in human plasma.Methods AB SCIEX HPLC-API4500QTRAP system was used in the method.Chromatographic separation was performed on PhonomenexKinetexXB-C18 column （100 mm × 2.1 mm,2.6 μm） using stepwise gradient elution of acetonitrile and water both with 0.2% formic acid.The analysis time was 3.5 min at a flow rate of 0.4 mL/min.The monitoring ion pairs of polymyxin B1,B2 and E2 were m/z 602.6→m/z 241.1,m/z 595.5→ m/z 227.1 and m/z 578.5→ m/z101.2,respectively.Polymyxin B was extracted from plasma by protein precipitation with acetonitrile.Results Polymyxin B1 showed a good linearity within the range of 0.05-10 mg/L （R~2 ＞ 0.98）.The intra-batch and inter-batch precisions were no more than 14.0% and the accuracy ranged from100.9% to 110.8%.The normalized matrix effect factor of polymyxin B1 was 92.6%-103.0% in normal and patient plasma,102.4%-112.6% in hemolytic samples,99.9%-104.7% in lipemic samples,and 97.1%-106.3% in patient serum.The recovery of polymyxin B1 was 79.1%-80.6%.Polymyxin B2 also showed a good linearity within the range of 0.005 50-1.10 mg/L.The precisions of intra-and inter-batch were no more than 14.8%.The accuracy was 97.6%-100.7%.The normalized matrix effect factor of polymyxin B2 was 73.6%-94.6% in normal and patient plasma,85.6%-120.6% in hemolytic samples,89.7%-103.4% in lipemic samples,and 82.6%-93.4% in patient serum.The recovery of polymyxin B2 was 83.2%-87.8%.Conclusions A simple,rapid,sensitive and accurate LC-MS/MS method was established for determination of polymyxin B1 and B2 in human plasma,and successfully applied for therapeutic drug monitoring of polymyxin B in patients.